Ainos (AIMD) announces the granting of a pivotal invention patent in Japan for its oral interferon formulation, VELDONA, to treat and prevent coronavirus infections. The newly granted patent includes 15 key claims that deliver comprehensive protection for VELDONA, covering its formulation, novel sublingual and buccal delivery mechanisms, and broad therapeutic applications
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIMD: